[{"address1": "1185 Avenue of the Americas", "address2": "Third Floor", "city": "New York", "state": "NY", "zip": "10036", "country": "United States", "phone": "844 967 2633", "website": "https://www.oramed.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins. It develops ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes. The company has license agreements with Oravax Medical Inc. to commercialize oral vaccines for COVID-19 and other novel coronaviruses. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York, New York.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Nadav  Kidron Esq.", "age": 50, "title": "President, CEO & Executive Chairman", "yearBorn": 1974, "fiscalYear": 2024, "totalPay": 872929, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Avraham  Gabay", "age": 39, "title": "CFO, Treasurer & Secretary", "yearBorn": 1985, "fiscalYear": 2024, "totalPay": 303065, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Joshua  Hexter", "age": 54, "title": "Chief Operating & Business Officer", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 422905, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Miriam  Kidron Ph.D.", "age": 84, "title": "Chief Scientific Officer & Director", "yearBorn": 1940, "fiscalYear": 2024, "totalPay": 583002, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.4, "open": 2.3393, "dayLow": 2.3393, "dayHigh": 2.42, "regularMarketPreviousClose": 2.4, "regularMarketOpen": 2.3393, "regularMarketDayLow": 2.3393, "regularMarketDayHigh": 2.42, "payoutRatio": 0.0, "beta": 1.681, "forwardPE": -30.125002, "volume": 31542, "regularMarketVolume": 31542, "averageVolume": 81453, "averageVolume10days": 90810, "averageDailyVolume10Day": 90810, "bid": 2.39, "ask": 2.44, "bidSize": 1, "askSize": 2, "marketCap": 98818680, "fiftyTwoWeekLow": 1.82, "fiftyTwoWeekHigh": 3.09, "allTimeHigh": 31.73, "allTimeLow": 1.67, "priceToSalesTrailing12Months": 49.40934, "fiftyDayAverage": 2.2108, "twoHundredDayAverage": 2.24985, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 844676, "profitMargins": 0.0, "floatShares": 32556858, "sharesOutstanding": 41003600, "sharesShort": 223986, "sharesShortPriorMonth": 364449, "sharesShortPreviousMonthDate": 1755216000, "dateShortInterest": 1757894400, "sharesPercentSharesOut": 0.0055, "heldPercentInsiders": 0.13161999, "heldPercentInstitutions": 0.17768998, "shortRatio": 2.25, "shortPercentOfFloat": 0.0063, "impliedSharesOutstanding": 41003600, "bookValue": 3.783, "priceToBook": 0.6370606, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "earningsQuarterlyGrowth": 0.442, "netIncomeToCommon": -24162000, "trailingEps": -0.61, "forwardEps": -0.08, "lastSplitFactor": "1:12", "lastSplitDate": 1358899200, "enterpriseToRevenue": 0.422, "enterpriseToEbitda": -0.062, "52WeekChange": -0.012295067, "SandP52WeekChange": 0.1529237, "quoteType": "EQUITY", "currentPrice": 2.41, "targetHighPrice": 3.25, "targetLowPrice": 3.25, "targetMeanPrice": 3.25, "targetMedianPrice": 3.25, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 97940000, "totalCashPerShare": 2.389, "ebitda": -13530000, "totalDebt": 912000, "quickRatio": 26.686, "currentRatio": 26.815, "totalRevenue": 2000000, "debtToEquity": 0.594, "revenuePerShare": 0.049, "returnOnAssets": -0.04941, "returnOnEquity": -0.14692001, "grossProfits": 13000, "freeCashflow": -4513625, "operatingCashflow": -16066000, "earningsGrowth": 0.409, "grossMargins": 0.0064999997, "ebitdaMargins": 0.0, "operatingMargins": -6.8365, "financialCurrency": "USD", "symbol": "ORMP", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": 0.416666, "regularMarketPrice": 2.41, "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1758917404, "regularMarketTime": 1758916800, "exchange": "NCM", "messageBoardId": "finmb_12191105", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1178026200000, "shortName": "Oramed Pharmaceuticals Inc.", "longName": "Oramed Pharmaceuticals Inc.", "postMarketChangePercent": 0.0, "postMarketPrice": 2.41, "postMarketChange": 0.0, "regularMarketChange": 0.00999999, "regularMarketDayRange": "2.3393 - 2.42", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 81453, "fiftyTwoWeekLowChange": 0.59000003, "fiftyTwoWeekLowChangePercent": 0.32417583, "fiftyTwoWeekRange": "1.82 - 3.09", "fiftyTwoWeekHighChange": -0.6799998, "fiftyTwoWeekHighChangePercent": -0.22006467, "fiftyTwoWeekChangePercent": -1.2295067, "earningsTimestampStart": 1762459200, "earningsTimestampEnd": 1762459200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.61, "epsForward": -0.08, "fiftyDayAverageChange": 0.19920015, "fiftyDayAverageChangePercent": 0.0901032, "twoHundredDayAverageChange": 0.16015005, "twoHundredDayAverageChangePercent": 0.07118254, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "displayName": "Oramed Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-09-27"}]